ENTRY       D03020                      Drug
NAME        Imiglucerase (USAN/INN);
            Imiglucerase (genetical recombination) (JAN);
            Cerezyme (TN)
PRODUCT     CEREZYME (Genzyme Corporation)
FORMULA     C2532H3843N671O711S16
EXACT_MASS  55537.0717
MOL_WEIGHT  55571.7149
SEQUENCE    ARPCIPKSFG YSSVVCVCNA TYCDSFDPPT FPALGTFSRY ESTRSGRRME LSMGPIQANH
            TGTGLLLTLQ PEQKFQKVKG FGGAMTDAAA LNILALSPPA QNLLLKSYFS EEGIGYNIIR
            VPMASCDFSI RTYTYADTPD DFQLHNFSLP EEDTKLKIPL IHRALQLAQR PVSLLASPWT
            SPTWLKTNGA VNGKGSLKGQ PGDIYHQTWA RYFVKFLDAY AEHKLQFWAV TAENEPSAGL
            LSGYPFQCLG FTPEHQRDFI ARDLGPTLAN STHHNVRLLM LDDQRLLLPH WAKVVLTDPE
            AAKYVHGIAV HWYLDFLAPA KATLGETHRL FPNTMLFASE ACVGSKFWEQ SVRLGSWDRG
            MQYSHSIITN LLYHVVGWTD WNLALNPEGG PNWVRNFVDS PIIVDITKDT FYKQPMFYHL
            GHFSKFIPEG SQRVGLVASQ KNDLDAVALM HPDGSAVVVV LNRSSKDVPL TIKDPAVGFL
            ETISPGYSIH TYLWHRQ
  TYPE      Peptide
REMARK      Therapeutic category: 3959
            ATC code: A16AB02
            Product: D03020<JP/US>
EFFICACY    Lysosomal storage disease treatment, Enzyme replacement (glucocerebrosidase)
  DISEASE   Gaucher disease [DS:H00126]
  TYPE      Enzyme replacement therapy product
TARGET      GBA* [HSA_VAR:2629v1] [HSA:2629] [KO:K01201]
  PATHWAY   hsa00600(2629)  Sphingolipid metabolism
            hsa00511(2629)  Other glycan degradation
            hsa04142(2629)  Lysosome
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AB Enzymes
                 A16AB02 Imiglucerase
                  D03020  Imiglucerase (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Imiglucerase
               D03020  Imiglucerase (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               395  Enzyme preparations
                3959  Others
                 D03020  Imiglucerase (USAN/INN); Imiglucerase (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Glycosidases
                GBA* [HSA_VAR:2629v1]
                 D03020  Imiglucerase (USAN/INN) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03020
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D03020
DBLINKS     CAS: 154248-97-2
            PubChem: 47205823
///
